Key result
Prediabetes progresses to diabetes at ~40 cases per 1000 person-years, highest above /dL glucose.
Cohort (n=10,796)
Yes
Answers are grounded in this paper and cite their sources.
Thirty-seven percent of US adults have prediabetes. Various interventions can delay diabetes progression; however, the optimum target group for risk reduction is uncertain. This study estimated rate of progression to diabetes at 1 and 5 years among a cohort of patients from 3 primary care clinics and modeled the potential magnitude in diabetes incidence risk reduction of an intervention program among specific subgroups. Records of 106,821 empaneled patients in 2005 were reviewed. Generalized population attributable risk (PAR) statistics were calculated to estimate the impact of reducing fasting blood glucose on diabetes progression. Multiple intervention effects (varying levels of glucose reduction along with multiple adherence rates) were examined for those with baseline glucose from 110 to 119 mg/dL and ≥120 mg/dL. Ten percent of patients (n = 10,796) met criteria for prediabetes. The 1- and 5-year diabetes incidence rate was 38.6 and 40.24 per 1000 person-years, respectively. Age and obesity were independent predictors of increased progression rate. The generalized PAR for a 10-point reduction in the 110-119 mg/dL subgroup with 25% adherence was 7.6%. The generalized PAR for similar percent reduction and adherence level in patients with baseline glucose of ≥120 mg/dL was only 3.0%. Rate of progression to diabetes increased over time and with associated independent risk factors. Greater risk reduction in diabetes progression within the target population can be achieved when the intervention is successful in those with baseline glucose of 110-119 mg/dL. Modeling an optimum target group for a diabetes prevention intervention offers a novel and useful guide to planning and allocating resources in population health management.
No takes yet. Share an insight, caveat, or question.
DeJesus et al. (2016) conducted a cohort in Prediabetes (n=10,796). Modeled 10-point reduction in fasting blood glucose vs. Baseline glucose ≥120 mg/dL subgroup was evaluated on Progression to diabetes. In patients with prediabetes, the 1- and 5-year diabetes incidence rates were 38.6 and 40.24 per 1000 person-years, with modeling suggesting greater prevention impact when targeting baseline glucose of 110-/dL.
Synapse has enriched 10 related papers. Consider them for comparative context: